Can determination of the proliferative capacity of the nontumor portion predict the risk of tumor recurrence in the liver remnant after resection of human hepatocellular carcinoma?
Jen‐Hwey Chiu, Li‐Hwa Wu, Hwa‐Li Kao, Hwey‐May Chang, Shyh‐Haw Tsay, Che‐Chuan Loong, Gar‐Yang Cha, Wing‐Yu Lui – 1 July 1993 – To test the hypothesis that increased proliferative capacity of cells in a liver remnant is a risk factor for tumor recurrence in patients who have undergone liver resection for hepatocellular carcinoma, DNA flow‐cytometric measurement and cell‐cycle analysis of the nontumor parts of resected hepatocellular carcinomas (tumor size <5 cm) were performed. The disease‐free survival rates 1, 2, 3 and 4 yr after surgery were 64%, 58%, 43%, and 36%, respectively.